Would You Support Race or Gender Identity-Based Hiring Practices?

Trending Polls:

Did Joy Behar's 'Cheeseburger' Remark About Trump Cross the Line?

Are You in Favor of Decriminalizing Hard Drugs?

Does Biden Care About Coal Miners?

Has Harvard University Become a Joke?

Does ‘Barbie’ Deserve an Academy Award?

Here’s the Scoop

A recent poll reveals a resounding majority of American voters are against race and sexuality-based hiring practices and the infiltration of Critical Race Theory into the medical field.

The poll, conducted by CRC Advisors for the 85 Fund, found that 66% of respondents opposed such practices, while only 22% supported them.

The DEI movement has been embraced by institutions across the country, including universities, corporations, and hospitals.

However, the poll results show that even a majority of Democrats and liberals (54% of both) oppose these discriminatory hiring and promotion practices. Republicans, conservatives, and independents all opposed the practices by more than 70%.

Major companies like NASCAR and IBM have implemented internships and career advancement opportunities that discriminate against white people, Asian people, and men in the name of DEI. The poll also found that 62% of respondents believe medical providers should not consider racial justice when determining treatments.

In addition, 59% of respondents said that state-owned hospitals and medical schools promoting and providing services based on race, gender identity, and sexuality should not receive taxpayer funding.

The poll also found that 61% of respondents disapproved of a new toolkit from the American College of Surgeons encouraging doctors to consider a patient’s race and identity when providing care.

Despite the unpopularity of race-based medicine, efforts to embed Critical Race Theory into the medical field under the banner of “health equity” continue.

The University of Minnesota’s School of Public Health provided politicized training protocols, while a top health policy journal hosted an internship that barred white applicants. The FDA even issued guidance prioritizing non-white patients for monoclonal antibody treatment for COVID-19.